Please assess the completion status of the following clinical trial:

Trial Title: A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female~* 18 years or older~* Diagnosis of type 1 or type 2 non-insulin dependent diabetes mellitus~* Chronic bilateral pain due to diabetic neuropathy, pain for at least six months.~* Primary pain is located in the feet.~* Subject participated in and completed the XTL 07-001 clinical trial.~Contact site for additional information.~Exclusion Criteria:~* Symptoms of other painful conditions~* Presence of amputations other than toes~* Clinically significant psychiatric or other neuropsychological disorder~* Use of certain medications~* Clinically important other diseases~* Pregnancy~* History of alcohol or narcotic abuse within two years.~Contact site for additional information.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Bicifadine 800 mg/day for a year
- 2 (Type: EXPERIMENTAL): Bicifadine 1200 mg/day for a year

Based on this trial design, predict the completion outcome and termination type (if applicable).